Health And Medicine
-
Neurotransmitter transporters expert Amara set for Oct. 7 Discovery Lecture
Susan Amara, PhD, scientific director of the Intramural Research Program at the NIMH and an expert on the biology of neurotransmitter transporters, will deliver Vanderbilt's next Discovery Lecture via Zoom at 4 p.m., Thursday, Oct. 7. Read MoreSep 29, 2021
-
Cohen Innovation Fund Awards Announced Supporting Two High-Risk, High-Reward Projects
Houra Merrikh, professor of biochemistry, and Teru Nakagawa, associate professor of molecular physiology and biophysics, have both been selected to receive one-year research awards from the Stanley Cohen Innovation Fund. The awards will support groundbreaking and paradigm-shifting research. Read MoreSep 28, 2021
-
Watch Now: Jason Isbell on addiction and sobriety with Vanderbilt Center for Addiction Research
Four-time Grammy Award-winning musician Jason Isbell spoke about the impact of COVID-19 on addiction and sobriety and the intersection of sobriety, addiction and music in the School of Medicine Basic Sciences' Lab-to-Table Conversation on Tuesday, Oct. 12, at noon CT. Read MoreSep 28, 2021
-
Jeffrey Conn, founding director of Warren Center for Neuroscience Drug Discovery, named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics
Jeffrey Conn, Lee E. Limbird Chair and professor of pharmacology, is among 16 scientists named 2021 fellows of the American Society for Pharmacology and Experimental Therapeutics. Selection as a fellow of ASPET is an honor bestowed on members who have demonstrated excellence in their efforts to advance pharmacology through scientific achievements, mentorship and service to the society. Read MoreSep 27, 2021
-
Study explores concussion recovery by race
Vanderbilt researchers are exploring the outcomes and experiences of Black and White athletes following a sports-related concussion. Read MoreSep 23, 2021
-
“Ultra-potent” antibody against COVID-19 variants isolated at VUMC
A technology developed at Vanderbilt has led to the discovery of an “ultra-potent” monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. Read MoreSep 22, 2021
-
What you need to know: Why Vanderbilt is conducting asymptomatic COVID-19 testing
Pam Jones, associate vice chancellor for health and wellness and co-commander of the university’s Public Health Central Command Center, discusses asymptomatic COVID-19 testing on campus, the goal of which is to detect and forecast possible infection trends and provide early warning signs of outbreak. Read MoreSep 20, 2021
-
Research Snapshot: True behavior of the ‘pleasure molecule’ will reshape how we treat psychiatric diseases and addiction
Discovery shows that dopamine is not a reward molecule at all, calling for revision of textbook facts regarding the hormone’s role in the brain. Est. reading time: 3.5 mins. Read MoreSep 15, 2021
-
Watch: The science and law behind medical marijuana, CBD and Delta 8
The School of Medicine Basic Sciences' monthly Lab-to-Table Conversation will discuss the science of marijuana and the current legal context for its use on Thursday, Sept. 23, beginning at noon CT. Read MoreSep 14, 2021
-
White matter and schizophrenia
Patients with schizophrenia have functional changes in the white matter of the brain, Vanderbilt researchers have discovered, which may contribute to impaired working memory and processing speed. Read MoreSep 2, 2021
-
Rheumatoid arthritis drug combined with standard of care may help reduce mortality for hospitalized COVID-19 patients
Hospitalized patients with COVID-19 who received the rheumatoid arthritis drug baricitinib, in combination with the standard of care including corticosteroids, died less often than those receiving only the standard of care, according to a study released this week. Read MoreSep 2, 2021
-
Discovery offers insight for development of cancer therapies targeting mutant p53
The tumor suppressor protein p53 is mutated in more than half of all human cancers. Several drugs that potentially can restore mutant p53 to its normal cancer-killing function are in clinical investigation. Read MoreSep 2, 2021
-
Ask an Expert: Is the COVID-19 vaccine safe for pregnant women?
Alexandra Speros, instructor in clinical nursing, midwifery and primary care, explains the latest expert guidance that encourages pregnant women to get the vaccine at any stage of their pregnancy. Read MoreAug 30, 2021
-
Research Snapshot: Novel finding shows that brain cells conduct antidepressant action even in the absence of activity
Even in the absence of brain activity, nerve cells can turn on gene expression that is important for antidepressant effects. This novel finding from Lisa Monteggia gives researchers a more fundamental understanding of the brain’s mechanistic function for better therapeutics. Est. reading time: 2.5 mins. Read MoreAug 30, 2021
-
Ask an Expert: Who does the vaccine protect?
Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, reminds us the reasons to get vaccinated. Read MoreAug 24, 2021
-
Ask an Expert: Is data about deaths after vaccination valid?
Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, explains how signals on deaths after COVID-19 is collected and interpreted. Read MoreAug 24, 2021
-
Ask an Expert: What do we know about the third dose option of the COVID-19 vaccine?
Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares information about the third dose of the COVID-19 vaccine, applicable to people with moderate to severe immunocompromise. Read MoreAug 24, 2021
-
Ask an Expert: What do we know about booster shots?
Thomas Talbot, professor of medicine and chief hospital epidemiologist at Vanderbilt University Medical Center, shares what we know about COVID-19 booster shots. Read MoreAug 24, 2021
-
Research Snapshot: Development of a new framework and tool for multi-drug synergy and combination
MuSyC is a technique to help researchers devise new combinations of drugs. An open-source analysis tool, it holds the promise speed such discoveries around the world. Read MoreAug 24, 2021
-
COVID-19 antibody ‘cocktail’ discovered at VUMC protects chronically ill: study
A monoclonal antibody cocktail against the COVID-19 virus discovered at VUMC is the first non-vaccine modified to demonstrate the prevention of COVID-19 in a clinical trial of more than 5,000 participants. The antibody treatment could afford up to 12 months of protection from COVID-19, and preliminary laboratory findings also suggest that it can neutralize the delta variant. Read MoreAug 20, 2021